Sermorelin vs CJC-1295 no DAC compared: half-life, dosing, cost, and research results, plus what US buyers should know before choosing either peptide.
Sermorelin and CJC-1295 no DAC are both growth hormone-releasing hormone (GHRH) analogs, but they are not interchangeable. The clearest difference is half-life: sermorelin breaks down in roughly 10 to 20 minutes, while CJC-1295 no DAC stays active for about 30 minutes because four amino acid substitutions protect it from DPP-4 enzymes. That single gap drives most of the other differences, including dosing frequency, cost, and how people stack them.
What Each Peptide Actually Is
Sermorelin is a 29-amino acid fragment of natural GHRH, matching the first 29 residues of the human hormone. It binds GHRH receptors in the pituitary and triggers a growth hormone pulse that resembles the body's own overnight release.
CJC-1295 no DAC, often written as mod GRF 1-29, is a modified version of that same chain. The four substitutions make it more resistant to enzymatic degradation, so it stays in circulation longer and produces a broader GH pulse.
The "no DAC" label matters. The original CJC-1295 carries a Drug Affinity Complex that binds albumin and stretches the half-life to about a week. Without that complex, the peptide behaves much more like a short-acting GHRH analog.
Sermorelin vs CJC-1295 No DAC at a Glance
Both compounds act on the same receptor and are typically injected subcutaneously. The practical differences come down to how long each one stays active and how often it has to be dosed.
| Feature | Sermorelin | CJC-1295 No DAC |
|---|---|---|
| Peptide type | Unmodified GHRH 1-29 fragment | Modified GRF 1-29 |
| Amino acids | 29 | 29 with 4 substitutions |
| Half-life | About 10 to 20 minutes | About 30 minutes |
| Albumin binding | No | No (the DAC version does bind) |
| Typical research dose | 100 to 300 mcg once nightly | 100 mcg, one to three times daily |
| FDA status | Formerly approved as Geref; discontinued in 2008 | Never approved for human use |
| Common stack partner | Used alone or with a GHRP | Frequently paired with ipamorelin |
What Does CJC-1295 No DAC Do Compared With Sermorelin?
People who type what does cjc 1295 no dac do into a search bar are usually asking whether it releases more growth hormone than sermorelin. In head-to-head research, both raise GH and IGF-1, but CJC-1295 no DAC tends to produce a larger peak per microgram because less of the peptide is destroyed before it reaches the pituitary.
Neither peptide replaces growth hormone itself. Both amplify the body's natural pulsatile release, so their effect depends on a functioning pituitary and on ordinary sleep and fasting patterns.
Dosing Frequency and Schedules
Dosage is where the two compounds diverge most in day-to-day use. A typical cjc-1295 no dac dosage chart lists 100 mcg per injection, with most people dosing once at bedtime or two to three times per day.
Sermorelin is usually dosed once nightly at 100 to 300 mcg. Because it clears so quickly, a single bedtime injection lines up with the largest natural GH pulse of the day.
These numbers come from research literature and community reports, not from FDA-approved labeling. Anyone considering personal use should discuss it with a licensed healthcare professional first.
Safety, Side Effects, and Legal Status
Both peptides are generally described as well tolerated in short-term research. Commonly reported effects include flushing, headache, injection-site irritation, and increased appetite shortly after dosing.
Stimulating growth hormone also raises IGF-1, and sustained IGF-1 elevation is a theoretical concern for people with cancer risk or active tumors. Sermorelin was FDA-approved in the 1990s as Geref for pediatric growth hormone deficiency, but that product was discontinued in the US in 2008. CJC-1295 no DAC has never been FDA-approved for human use.
Access is another dividing line. Sermorelin is available as a compounded prescription product through licensed pharmacies. People who search to buy cjc-1295 no dac typically find it sold as a lyophilized research chemical labeled "not for human consumption," which means no purity oversight and no dosing guidance from a clinician.
Both peptides are also banned by WADA for athletes in competition.
How People Choose Between Them
- Dosing convenience: Sermorelin is one injection at night; CJC-1295 no DAC is often dosed two or three times daily.
- Cost per month: Sermorelin requires larger amounts per dose, while CJC-1295 no DAC is used in smaller amounts more often.
- Legal access: Sermorelin can be prescribed by a physician; CJC-1295 no DAC is sold only as a research chemical.
- Stacking: CJC-1295 no DAC is frequently combined with a GHRP such as ipamorelin, which acts on a separate receptor pathway.
Stacking is one of the most discussed topics in peptide forums, and the pairing of CJC-1295 no DAC with ipamorelin is said to produce a larger combined pulse than either alone. Most of what people read when they search cjc 1295 no dac vs sermorelin online comes from forums and vendor pages rather than controlled human trials.
Tesamorelin vs sermorelin vs cjc-1295 is another comparison that comes up often, and tesamorelin is the only one of the three with a current FDA approval, which is for HIV-associated lipodystrophy.
The Bottom Line
Sermorelin is the shorter-acting, more physiologic option with an FDA history behind it. CJC-1295 no DAC is the longer-lasting analog used mostly in research settings, where it is valued for its resistance to enzymatic breakdown.
Neither peptide is a proven anti-aging treatment, and neither should be started without medical supervision. If you are weighing them for personal use, the deciding factors are usually dosing convenience, legal access, and cost rather than a dramatic difference in what the peptides do.
Frequently Asked Questions
Is CJC-1295 no DAC the same thing as sermorelin?
No. Both are GHRH analogs that act on the same pituitary receptor, but CJC-1295 no DAC has four amino acid substitutions that help it resist enzymatic breakdown. Sermorelin is the unmodified 29-amino acid GHRH fragment, so it clears faster and is usually dosed once at night.
Which one raises growth hormone more, sermorelin or CJC-1295 no DAC?
Per microgram, CJC-1295 no DAC is generally described as the stronger of the two because less of the peptide is degraded before it reaches the pituitary. Sermorelin's shorter half-life means it must be dosed more often, but its pulse more closely matches the body's natural overnight release. Human head-to-head trials are limited, so most comparisons rely on smaller studies and anecdotal reports.
Is CJC-1295 no DAC legal to buy in the US?
CJC-1295 no DAC is not FDA-approved for human use and is sold online as a research chemical labeled "not for human consumption." Sermorelin requires a prescription and is dispensed by compounding pharmacies, although the original FDA-approved brand product was discontinued in 2008. Buying or importing unapproved peptides carries both legal and safety risks.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.